List of Cancer Targeted Technology patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11225496 Chelated PSMA inhibitors	Patent 11225496 was granted and assigned to Cancer Targeted Technology on January, 2022 by the United States Patent and Trademark Office.	‌ Cancer Targeted Technology	‌ Cancer Targeted Technology	United States Patent and Trademark Office	11225496	January 18, 2022
‌ US Patent 9974869 Chelated PSMA inhibitors	Patent 9974869 was granted and assigned to Cancer Targeted Technology on May, 2018 by the United States Patent and Trademark Office.	‌ Cancer Targeted Technology	‌ Cancer Targeted Technology	United States Patent and Trademark Office	9974869	May 22, 2018
‌ US Patent 11147889 Albumin-binding PSMA inhibitors	Patent 11147889 was granted and assigned to Cancer Targeted Technology on October, 2021 by the United States Patent and Trademark Office.	‌ Cancer Targeted Technology	‌ Cancer Targeted Technology	United States Patent and Trademark Office	11147889	October 19, 2021
‌ US Patent 10166301 Chelated PSMA inhibitors	Patent 10166301 was granted and assigned to Cancer Targeted Technology on January, 2019 by the United States Patent and Trademark Office.	‌ Cancer Targeted Technology	‌ Cancer Targeted Technology	United States Patent and Trademark Office	10166301	January 1, 2019
‌ US Patent 9446157 Chelated PSMA inhibitors	Patent 9446157 was granted and assigned to Cancer Targeted Technology on September, 2016 by the United States Patent and Trademark Office.		‌ Cancer Targeted Technology	United States Patent and Trademark Office	9446157	September 20, 2016